Obesity Nutritional, Metabolic, Endocrine Obesity
Conditions
Interventions
The children and their families are followed at the out-patient clinic at the Pediatric Department at 7 consultations during one year. Three visits are individual and included physical examination by
Sponsors
Regional Hospital Viborg
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged between 11-13 years 2. BMI = 22 (this value at the age of 12 years old correlates to BMI of 25 in an adult)
Exclusion criteria
Exclusion criteria: Considerable comorbidity which would make participation in structural physical activity impossible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The degree of weight loss and weight changes. Weight, height and BMI was registrated every third month during the intervention period. 2. Changes in adiponectin, leptin and c-reactive protein (CRP) are measured before and after the intervention. Adiponectin (mg/l) is determined by a validated in-house time-resolved immunofluorometric assay based on two monoclonal antibodies and recombinant human adiponectin (obtained from R&D Systems, Abingdon, UK). Leptin (µg/l) is determined by a validated in-house time-resolved immunofluorometric assay based on commercial available monoclonal antibodies and recombinant human leptin (R&D Systems, Abingdon, UK). CRP levels are determined by a high sensitive CRP (hsCRP) TRIFMA assay based on commercial available monoclonal antibodies (R&D systems). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Waist circumference, measured every third month during the intervention. 2. Hip circumference, measured every third month during the intervention. 3. Blood pressure, measured every third month during the intervention. | — |
Countries
Denmark
Outcome results
None listed